Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis (Q44593368)
Jump to navigation
Jump to search
scientific article published on 2 March 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis |
scientific article published on 2 March 2010 |
Statements
1 reference
Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis (English)
1 reference
Matthias Jürgens
1 reference
Rüdiger P Laubender
1 reference
Franziska Hartl
1 reference
Maria Weidinger
1 reference
Julia Seiderer
1 reference
Johanna Wagner
1 reference
Martin Wetzke
1 reference
Florian Beigel
1 reference
Simone Pfennig
1 reference
Johannes Stallhofer
1 reference
Fabian Schnitzler
1 reference
Cornelia Tillack
1 reference
Peter Lohse
1 reference
Burkhard Göke
1 reference
Jürgen Glas
1 reference
Thomas Ochsenkühn
1 reference
Stephan Brand
1 reference
2 March 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference